A total of 416 gastric cancer surgical specimens were collected for HER2 detection, and the positive rate of HER2 was 9.13% (38/416), including 33 males (9.68%) and 5 females (6.67%), with no statistical significance (P >.05). The gene discussed is ERBB2; the disease is gastric cancer.